Role of â??Darvyadi Kwathâ?? andâ??Triphla Kwathâ?? in Ekakushtha(Plaque psoriasis)

A comparative study to evaluate the effectiveness of â??Darvyadi Kwathâ?? and â??Triphla Kwathâ?? in management of Ekakushtha(Plaque psoriasis)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/05/042491

Enrollment

Registered

2022-05-12

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L400- Psoriasis vulgaris

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: a. Age: 20 year to 60years. b. Sex: both sex(male and females). c. Patient having the clinical feature of Ekakushtha(Plaque Psoriasis). d. Patient having chronicity of psoriasis less than 5 year and more than 6 month. e.Patient willing to give consent for trial with firm residential address and contact.

Exclusion criteria

Exclusion criteria: a. Age: - less than 20 year and more than 60 years. b. Patient suffering from Diabetes Mellitus, Cancer, Cardiac Problems, Uncontrolled Hypertension, Acquired Immunodeficiency Syndrome (AIDS), Tuberculosis (TB), Renal c. Disorder. d. Other co-skin disease. e. Pregnant women and lactating mother. f. Drug or Alcohol Abuse: A Known or suspected history of chronic alcohol or drug abuse. g. Hypersensitivity to any of the drugs to be used in study.

Design outcomes

Primary

Measure	Time frame
Improvement in Psoriasis Area And Severity Index(PASI) ScoreTimepoint: DAY 1 DAY 15 DAY 30 DAY 45	—

Secondary

Measure	Time frame
Improvement in inflammatory markers (ESR, CRP).Timepoint: DAY 1 DAY 15 DAY 30 DAY 45;Improvement in symptom severity of Ekkushtha(Plaque Psoriasis). Timepoint: DAY 1 DAY 15 DAY 30 DAY 45	—

Countries

India

Contacts

Public ContactDr Priyanka

Ch Brahm Prakash Ayurved Charak Sansthan

kasdepriyanka15@gmail.com7000940468

Outcome results